dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
synagis 100mg/ml i.m. vial
سيناجيس 100 مجم /مل حقن
palivizumab · 100 mg/ml
12000EGP
Available
Active ingredient
palivizumab
Strength
100 mg/ml
Form
vial
Manufacturer
abbvie ltd. > multipharma
Route
injection

Uses

Used to prevent serious lower respiratory tract disease caused by RSV in high-risk infants and young children, including premature infants and certain patients with bronchopulmonary dysplasia or significant congenital heart disease.

Do not use if

Previous significant hypersensitivity reaction to palivizumab or any component of the product.

Side effects

Fever, rash, injection-site reactions, and hypersensitivity reactions may occur. Rarely, severe allergic reactions including anaphylaxis can occur.

Warnings

Severe hypersensitivity and anaphylaxis may occur. Discontinue permanently if a serious allergic reaction develops.

How it works

Humanized monoclonal antibody with activity against respiratory syncytial virus, used for passive immunization.

Storage

Store refrigerated at 2–8°C in the original container. Do not freeze.